Re:The Aducanumab Approval
by tptacek on Tuesday June 08, 2021 @02:21PM
(#27438867)
Not for nothing, but, despite all the airtime this issue gets, my understanding is that pharmaceuticals are a pretty small component of health care spending; like, if you zeroed it out, you'd get less than a grocery store discount.
[ Parent
| on HN ]
Data for 2019 [0]:
> NHE grew 4.6% to $3.8 trillion in 2019, or $11,582 per person, and accounted for 17.7% of Gross Domestic Product (GDP).
> Prescription drug spending increased 5.7% to $369.7 billion in 2019, faster than the 3.8% growth in 2018.
So that is around 10%. Still a pretty high amount of money.
[0] https://www.cms.gov/Research-Statistics-Data-and-Systems/Sta...
Re:The Aducanumab Approval
by hn_throwaway_99 on Tuesday June 08, 2021 @06:07PM
(#27441638)
I disagree. See https://www.politifact.com/factchecks/2019/feb/22/amy-klobuc... (drug costs come between 15-17% of total spending). And given how you can divvy up spending (drugs, facilities, doctors, nurses, admin staff, overhead, etc.), one sixth of total spending seems like a very large amount.
And, it's especially the case that for certain individuals (this page also made the top of HN today, https://www.goodrx.com/blog/most-expensive-drugs-period/) that drug costs are a gargantuan, total-lifetime-salary kind of expenditure.